ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.
Melanoma and other Skin Tumours
Latest ESMO videos
Featured medwireNews
Adjuvant PD-1 Inhibitor Chronic Immune-Related AEs Highlighted In Advanced Melanoma
Stage III High-Risk Melanoma Benefits With Dabrafenib–Trametinib, Pembrolizumab
Continuous BRAF–MEK inhibition Best For BRAF-Mutated Melanoma
Immune-Related Adverse Event Risks Differ By ICI Regimen in Advanced Melanoma
COMBI-AD Biomarker Analysis May Help Guide Stage III Melanoma Care
E-Learning
ESMO V-Learning: BRAF Mutations Across Cancers
ESMO E-Learning: New Treatments in Melanoma
ESMO V-Learning: Inhibition of MEK to Treat Cancer, focussing on Melanoma
Factsheets on Biomarkers
PD-L1 in Cancer: ESMO Biomarker Factsheet
NRAS in Melanoma: ESMO Biomarker Factsheet
BRAF in Melanoma: ESMO Biomarker Factsheet
Meeting resources
19O - Preliminary safety, antitumor activity and pharmacodynamics results of HIT-IT MEDI1191 (mRNA IL-12) in patients with advanced solid tumours and superficial lesions
Presenter: Omid Hamid
Session: Proffered Paper session
Resources:
Abstract
Slides
Webcast
Oncolytics, radiation and other combinations
Presenter: Kevin Harrington
Session: Where next with oncolytics?
Resources:
Slides
Webcast
Melanoma: Immune Checkpoints and Combination therapies
Presenter: J.Haanen, NL
Session: Session 2 - Clinical development
Resources:
Slides
Webcast
The role of B-cells and tertiary lymphoid structures in response to immune checkpoint inhibitors
Presenter: Göran Jönsson
Session: B-cell biology
Resources:
Slides
Webcast
64MO - A phase (ph) II, multi-center study of the safety and efficacy of tebentafusp (tebe) (IMCgp100) in patients (pts) with metastatic uveal melanoma (mUM)
Presenter: Joseph Sacco
Session: Mini Oral session 2
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.